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Background: In the past years, significant progress has been made to develop and use experimental settings for
extensive data collection on tobacco smoke exposure and tobacco smoke exposure-associated diseases. Due to the
growing number of such data, there is a need for domain-specific standard ontologies to facilitate the integration
of tobacco exposure data.
Results: The CSEO (version 1.0) is composed of 20091 concepts. The ontology in its current form is able to capture
a wide range of cigarette smoke exposure concepts within the knowledge domain of exposure science with a
reasonable sensitivity and specificity. Moreover, it showed a promising performance when used to answer domain
expert questions. The CSEO complies with standard upper-level ontologies and is freely accessible to the scientific
community through a dedicated wiki at https://publicwiki-01.fraunhofer.de/CSEO-Wiki/index.php/Main_Page.
Conclusions: The CSEO has potential to become a widely used standard within the academic and industrial
community. Mainly because of the emerging need of systems toxicology to controlled vocabularies and also the
lack of suitable ontologies for this domain, the CSEO prepares the ground for integrative systems-based research in
the exposure science.
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Recently, there has been an increased focus in systems
toxicology on systems-oriented methodologies that
emphasize the understanding on the biological impact of
chemical exposures with increased mechanistic granularity
[1,2]. In particular, a recent report by the US National
Research Council Committee on Toxicity Testing and
Assessment of Environmental Agents advocates for a shift
away from toxicological assessment at the level of apical
endpoints towards the understanding of the effects of an
exposure on toxicity pathways [3]. Moreover, the Food
and Drug Administration (FDA) recently describes a
system-based omics-approach to discover pulmonary
biomarkers and to improve the evaluation of tobacco
products [4]. This indicates a growing recognition that
exposure science should be considered as an integrated
part of a systematic approach for risk assessment [5].* Correspondence: sam.ansari@pmi.com
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reproduction in any medium, provided the orTo assess biological responses to environmental
exposure, a systems-based approach attempts to apply an
integrative strategy. A systems-based approach integrates
a continuous model from the starting point of exposure to
disease outcome [6]. A typical limitation in systems
approaches is the lack of standards for harmonization of
heterogeneous data types that are experimentally obtained
from different resources. Such data types often have
various structures, formats and annotations, which
adversely affect the degrees of their interoperability and
flexibility for integrative methods. Standard terminologies
and proper contextual information are necessary for data
sharing, reuse, and integration [7]. Recently, biomedical
ontologies have emerged in support of systems approaches
by facilitating the annotation of bio-simulation models
and flexible access to knowledge [8]. The main purpose of
ontologies is to organize data and information of a
particular knowledge domain in a structured, controlled,
and standard manner. Thus the data can be shared among
scientists in different research areas or accessed and
interpreted using different computational tools. The core
of any ontology is a controlled vocabulary that attempts to
describe a unified definition for all terms and concepts inl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Ontology (GO) that provides a controlled vocabulary
describing the roles of genes and their products in various
organisms [10].
At the heart of systems toxicology is the understanding
of signaling pathways perturbed by biologically active
substances and the identification of those that have the
potential to cause adverse health effects in humans. This
requires integrating OMICs data with in vitro and in vivo
toxicological endpoints. The goal of systems toxicology is
therefore to link disease susceptibility at the molecular
level to environmental stress or toxicant effect at the
clinical level. Despite advances in various aspects of
toxicogenomics, semantic representation of toxicological
data and endpoints is still in its infancy. A variety of tools,
platforms, and workflows coexist but each uses its own set
of terms and ontologies, a challenge for data exchange.
Hardy et al. [11] in their review provide an overview of
existing toxicology vocabularies and ontologies that are
currently being used in predictive toxicology initiatives
and applications [11].
Recently, the toxicology OpenTox ontology has been
developed to support standard representation of
relations between chemical and toxicological datasets
and experiments by unified terms. It is part of the
OpenTox framework, which aims at unifying access to
toxicity data, predictive networks, and validation procedures
[12]. One of the advantages of the OpenTox ontology is the
combination of several related ontologies that cover
common information for chemical compounds, chemical
datasets, algorithms, models, assays, in vivo studies, and
toxicological endpoints. Moreover, when integrated in a
semantic environment, the OpenTox ontology service
facilitates registering new resources, remote access, and
searching datasets using SPARQL. However, the OpenTox
remains a high-level ontology and does not include concept
granularity for the majority of its components in particular
for the domain of environmental exposure.
Lately, the exposure ontology (ExO) has been proposed
to provide the missing link between exposure science and
various environmental health disciplines, including
toxicology [13]. The main advantage of the ExO is that it
provides the first semantic template for representation of
exposure information around the following four root
concepts: exposure stressor, exposure receptor, exposure
event, and exposure outcome. Although the current
version of the ExO includes very general and high-level
concepts to cover the breadth of the exposure knowledge
domain, it still lacks sufficient granularity that is required
to capture detailed information. Besides, the ExO is not
compliant with the proposed upper-level ontology
standards such as the Basic Formal Ontology (BFO) [14]
or the Descriptive Ontology for Linguistic and Cognitive
Engineering (DOLCE) [15], which makes its integrationwith existing or new ontologies semantically more
difficult. Furthermore, Thomas et al. [16] describe the
use of a Smoking Behavior Risk Ontology (SBRO) to
represent risk models for phenotypes associated to
tobacco smoking behavior [16]. However, the scope of
their ontology is limited to nicotine pharmacokinetics,
pharmacodynamics, nicotine dependence, and clinical
smoking cessation outcomes.
Exposure to tobacco smoke is considered an environ-
mental risk factor to human health and it is involved
in the initiation and progression of several respiratory
diseases including chronic obstructive pulmonary dis-
eases (COPD) and lung cancer [17,18]. Elimination or
minimization of exposure to cigarette smoke provides a
clear opportunity to prevent related diseases. Although
experiments that measure exposure to environmental
tobacco smoke follow – to a large extent – the typical
protocols used in toxicology experimental settings, no
semantic framework capturing information specific to the
domain of cigarette smoke exposure risk is available.
In response to the need for semantic representation of
the environmental exposure knowledge domain with
particular focus on the cigarette smoke exposure risk,
the Cigarette Smoke Exposure Ontology (CSEO) was
developed.
Results
Purpose of the cigarette smoke exposure ontology
The development of an ontology starts by defining its
domain and scope. The scope of the CSEO was defined
based on the potential application of the ontology in the
domain of environmental exposure and was focused on
exposure to cigarette smoke. Since setting a proper
scope helps draw boundaries to the knowledge domain
included in the ontology, the CSEO is intended to
include all concepts and terms that represent processes
and elements involved in conducting cigarette smoke
exposure experiments, in association with cigarette-smoke
related diseases (Figure 1).
The scope of the ontology revolves around the ‘exposure
experiment’ concept and covers description of sampling
and experimental factors, test items, test systems, exposure
condition, and link to diseases. These are the main
concepts to be included in the CSEO by following the life
cycle of ontology building, as described in the Methods
section. Axiomatisation of concepts in the CSEO is based
on the axioms provided in the BFO and ExO. For example,
the description of an exposure follows the lines of the
“exposure event” class in the ExO. We have, furthermore,
enriched the ExO classes with extra classes that make the
ontology more specific to cigarette smoke rather than just
to exposures in general. The reason for choosing these
concepts is that they represent the major players in systems
toxicology studies conducted in the domain of smoke
Figure 1 High-level schematic representation of the CSEO scope. The scope of CSEO was designed around the key concept of exposure
experiment and its substantial elements.
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routine summarized as follows: the design, factors, and
protocols of an experiment must be defined before
conducting the experiment. This is often the case for
exploratory systems-based approaches and lesser the case
for validated assays. The two main components of an
experiment are often a test system and test item, where the
test system describes the exposure receptor (e.g., a clinical,
in vivo, or in vitro setup), and the test item describes the
exposure stressor (e.g., chemical compounds, cigarette
smoke, and its characterization). Both of these components
require terms that clearly specify the items. These two
components interact in an exposure experiment and their
interaction is described by the exposure conditions, for
example, exposure transport path, frequency, and doses.
The exposure condition, therefore, connects the test
system and the test items under the experiment description.
The exposed test system itself includes sampling proce-
dures, which are bound to various endpoint measurements.
In the case of systems-based approaches, the sampling
procedures cover a large number of procedures. The
sampling of the test items together with the endpoint
measurements leads to an outcome, which may be
associated with respiratory system diseases.
The main purpose of the ontology is to support annota-
tion of experimental data sets such as the details of the
experiment and its design, description of test item, test
system, as well as the exposure path to outcomes.
Additional file 1 shows an example on the use of CSEO to
annotate experiments. GeneChip Microarray experi-
ments generate high-throughput transcriptomic data
that can be reused for other research topics than the
originally designed experiment. Therefore, the FGED(Functional Genomics Data) society created standards
to exchange these and other similar data types related to
functional genomics. These standards not only include the
format of exchange but also the minimum requirements
for experimental annotation so that experimental data can
be correctly reproduced and reused. The exchange file
format is called MAGE-TAB [19], which includes an
IDF file for the definition of the investigation, a SDRF
file for the specification of each sample, and an ADF
file for the specification of the microarray analyte layout.
This file format is supported by the repository ArrayExpress
[20] and gives open access to a large number of functional
genomics datasets.
While MAGE-TAB defines the exchange format, there
is another standard that describes the required annotation
level, MIAME [21] the Minimum Information About
a Microarray Experiment. Additional file 1 shows an
example of the SDRF file that is MAGE-TAB and
MIAME compliant. Each row indicates the biological
samples with annotations and protocols for biological
sample transformation. The data model starts with a
subject, which is an animal model including additional
information about type, strain, and gender. When a protocol
applies, the biomaterial is changed, here from an untreated
animal to a treated animal. The treatment is further
described with the exposure item, brand, smoking regimen,
nicotine concentration, exposure path, and exposure
duration. The next protocol defines a post-exposure
treatment and affects only part of the samples. After
all exposures, the animal is dissected into organ parts
that are described by the next protocol. The organ
part is now further defined as frozen alveolar tissue area
from left lung of each animal. The next protocols define
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hybridized on a GeneChip. The SDRF file ends with the
reference to the raw data file names, processed data file
name, and a summary of all experimental factor values.
All protocols are defined in the IDF file (not shown).
MAGE-TAB requires the use of ontology defined
terms. The ontology resource is specified with location
and version in the IDF. Yellow marked columns in
Additional file 1 show the CSEO annotations that
cover a large fraction of the SDRF file and ensure rich
and proper annotation. The annotation level of this file is
much richer than the MIAME requirement and supports
the reproducibility and reusability of experimental data.
Furthermore, conceptualizing and organizing this
knowledge domain in the form of an ontology allows
efficient augmentation of biological knowledge retrieval
and extraction. Therefore, the sensitivity to which
biological mechanisms are modulated in response to
different risk factors posed by smoking toxicants in
the lungs can be captured.
Framework and architecture of the CSEO
The CSEO was designed to be compliant with the Basic
Formal Ontology (BFO). The BFO was adopted to define
the upper-level standard architecture. The BFO is designed
to support development of domain ontologies for scientific
research [22]. On the other hand, the ExO is the only
existing and intuitive semantic framework used by the
exposure science community that provides a good
template for plugging in subdomain ontologies related
to the exposure domain. Therefore, the ExO superclasses
were used as root concepts for the CSEO. Accordingly,
the CSEO populates the ExO for the concepts of theFigure 2 Schematic representation of the main ontology classes and
blue: is-a relations; yellow: ExO: is_associated_with; orange: ExO: interacts_w
violet: ExO: interacts_with.cigarette smoke risk subdomain and also complies
with requirements of the OBO Foundry and RO
(Relation Ontology). Figure 2 depicts the architecture
of the CSEO in relation to BFO and ExO and its main
classes. Such an architecture is expected to incorporate
provenance into the CSEO so that concepts can be traced
back to their corresponding upper-level classes in ExO
and BFO.
The CSEO comes in two different versions: the main
CSEO version is a BFO-compliant ontology, and the
second version is a controlled vocabulary version,
hereafter referred to as “lexical version”. The CSEO-BFO
version consists of the BFO top-level hierarchy into
which the adjusted ExO hierarchy was plugged. The
CSEO classes were organized underneath these layers as
a third layer of granularity. This is the so-called
“computer-readable” format of the CSEO, which
represents the formal ontology. The lexical version, on
the other hand, forms the so-called “expert-readable”
format and does not claim to be a standard-adhering
ontology in itself. Instead, it is an access point to the
CSEO classes that is intuitive and easy to navigate for
medical and biological experts. This lexical version
supports the creation and review of the ontology by
various experts within the field. It, furthermore, creates
a categorization of ontology classes and terms into
‘context categories’ inside the knowledge domain. This is
usable also for context-sensitive text mining i.e., it
contains a branch that collects all terms related to
exposure outcomes (including terms which are not
necessarily exposure types) compared to the CSEO-BFO
version where they have to be collected manually. Both
versions are available on the CSEO dedicated wiki website.class provenance between BFO, ExO, and CSEO. Arrow legend:
ith_an_exposure_stressor_via; brown: MGED: has_experiment_ design;
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Structural measure
Measurement of the structural dimension of the ontology
reflects the organizational patterns of the concepts in
the ontology. The first draft of CSEO (version 1.0) is
composed of 20091 concepts, including the BFO and
ExO classes. Additional file 2 provides several metrics
on structural properties of the ontology. These metrics
include ‘breadth’, which relates to the cardinality of paths;
‘depth’, which relates to the cardinality of paths in a
graph; ‘tangledness’, which relates to multi-hierarchical
nodes; and ‘fanout factor’, which relates to the dispersion
of nodes.
As shown in Additional file 2, the high number of
classes and leaves together with high values for average
width and the fanout factor, point towards a broad
coverage of concepts by the ontology whereas the values
for depth show specificity of the concept types to the
domain of cigarette smoke exposure risk. The tangledness
factor of 0.71 indicates the presence of multi-hierarchical
nodes in the ontology (i.e. categories having multiple
parents). This is beneficial when greater crosslinking of
the domain concepts is desired. Different relation types
from RO were used to relate concepts in the CSEO
including ‘part_of ’, ‘precedes’, ‘has_participant’, etc. Figure 2
illustrates the relational view of the second-level concepts
in the CSEO.
Functional measure
Measuring the functional dimension of the ontology
indicates how well the conceptualization of the ontology
captures the semantic space of the knowledge domain. The
lexicalized ontology was used to calculate precision, recall,
and F-score values (69.23, 77.81, 73.26, respectively).
The result of this evaluation shows that the ontology
in its current form is able to capture a wide range of
concepts related to cigarette smoke exposure in the
knowledge domain of exposure with a reasonable sensitivity
and specificity towards manual curation. The F-score of
above 73% reflects the quality output of the ontological
search in the published knowledge domain of cigarette
smoke exposure risk.
Usability profile
Usability profile of an ontology is defined by the extent of
user-friendliness of the ontology in terms of easy navigation,
knowledge accessibility, and meta-information availability.
Navigation of the CSEO and its user interface has been
facilitated using the WebProtégé software, which provides a
web-based access to the content of the ontology without
the need for software installation [23]. By following the
hyperlink provided on the wiki website under “CSEO
access”, the user is directed to the WebProtégé page in
which clicking CSEO launches the formal BFO-compliantontology whereas clicking CSEO-Expert Readable hyperlink
launches the hierarchy of controlled vocabulary underlying
CSEO. The search field makes it possible to search for any
CSEO-related concept and locate it in the tree (Figure 3).
Feedbacks can be provided through the same portal and a
dedicated team will process them.
To increase the level of efficiency in accessing different
views (subdomains) of the ontology, the ExO root concepts
were used for further classification of the CSEO instants.
By this means, tracking exposure-specific concepts for
users becomes easier and more efficient. Meta-information
(i.e. annotations including synonyms, definition, and
reference) is provided for each concept in the CSEO
to enable users accessing relevant information.
Since a proper documentation is needed to ensure
direct access and efficient usability of the ontology, a
wiki environment was created that contains instructions for
using the ontology, documentation on purpose and scope of
the ontology, and information about interfacing to the
ontology. The wiki is accessible through the following
hyperlink in FireFox and Safari browsers: https://publicwiki-
01.fraunhofer.de/CSEO-Wiki/index.php/Main_Page.
Use-case scenario: answering competency questions by
experts
Ontology-driven information retrieval and extraction
systems will guide analysis of literature in precisely
answering complex scientific questions [24]. The lexicalized
form of the CSEO was used to automatically retrieve
and extract domain specific knowledge related to
cigarette smoke exposure risk from PubMed abstracts
(see Methods). Experts in the knowledge domain of
cigarette smoke exposure risk were asked to design
several complex questions to be posed to the ontology.
The following questions were considered to test the
performance of the ontology:
– What are the potential effects of the toxicity
induced by tobacco smoke constituents on smokers?
– Which toxicological studies are available that
measure total particulate matter in electrically
heated cigarettes?
– Which documents report on the use of experimental
mouse models for investigating the effect of
cigarette smoke exposure on the risk of COPD?
Queries were formulated in the SCAIView environment
using the CSEO terminology. SCAIView displays named
entities by markup of the text (e.g. PubMed abstracts).
The key feature of SCAIView is the possibility to perform
ontological search in biomedical text using concept
hierarchies and synonyms associated with each concept in
the ontology. While using the ontology in SCAIView, the
hierarchical organization of the ontology was preserved by
Figure 3 Illustration of term search and navigation through the CSEO.
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structure. Subsequently, retrieved documents were
manually checked for containing correct answers to
the posed competency questions. Table 1 summarizes these
queries, their corresponding retrieval rate, and reference to
the relevant documents that contain correct answers
to competency questions. Titles of both relevant and
irrelevant abstracts are listed in Additional file 3.
These results indicate that application of the CSEO-
derived terminology to the semantic literature search
leads to retrieval of highly relevant publications containing
the correct answer to the posed competency question.
Moreover, highlighted CSEO concepts (terms) by
SCAIView allow users to detect and extract knowledge
statements, as illustrated in Figure 4. The CSEO termin-
ology can be accessed through the SCAIView search
engine under: www.scaiview.com/scaiview-academia.html.
Discussion
The CSEO covers relevant concepts in the field of
systems-based toxicology assessment and includes manyTable 1 Answering competency questions using CSEO-driven
Query (22.03.2013) No. of retrieved
docs:
(([CSEO: “Smoke Constituent”]) AND [CSEO:“ Toxicity”])
AND [CSEO: “Tobacco”]
21
([CSEO: “Electrically heated cigarette”]) AND [CSEO:
“Total Particulate Matter”]
7
(([CSEO: “Mouse model”]) AND [CSEO: “Cigarette Smoke
Exposure”]) AND [MeSH Disease: “Pulmonary Disease
Chronic Obstructive”]
9terms from the conventional toxicology assessment. Thus,
the CSEO enables users to capture and integrate exposure
information from the beginning of the experiment to the
point of outcome measurement. Compared to other
relevant ontologies, the CSEO covers a large number
of concept classes including the 44 external ontologies.
Additionally, the CSEO uses semi-automated methods for
the term extraction and evaluation and therefore ensures
good coverage of the knowledge domain.
Another advantage of the CSEO over the existing
related ontologies is the enrichment of high-resolution
concepts that extends the higher-level exposure ontology
in areas where existing ontologies are particularly weak.
For instance, the CSEO describes mouse and rat strains
that are commonly used in exposure experiments,
includes human anatomy with a dedicated subclass to
microanatomy of the respiratory system, and articulates
staging of progressive diseases. Moreover, the CSEO can
be used for text mining and knowledge discovery purposes
because the CSEO is a lexicalized ontology that supports
ontology-driven information retrieval and extraction assemantic search in PubMed abstracts
No. of relevant
docs:
PMIDs of relevant documents:
17 (80.95%) 14521141 [25], 1188959 [26], 18848577 [27], 21651432
[28], 17661226 [29], 2002748 [30], 12857635 [31],
19330121 [32], 14698566 [33], 11731039 [34],
18383128 [35], 16859820 [36], 21651433 [37],
21417965 [38], 2165143 1[39], 15072838 [40] ,
18464053 [41]
7 (100%) 12975773 [42], 12975774 [43], 14698566 [33], 12975771
[44], 18590791 [45], 12975772 [46], 16963170 [47]
9 (100%) 20133926 [48], 19017996 [49], 23044435 [50], 22279084
[51], 18988919 [52], 21700603 [53], 20228194 [54],
19491340 [55],16510458 [56]
Figure 4 An example of highlighted CSEO terms in the PubMed abstracts as appears in the SCAIView environment. The highlighted
terms guide users to informative statements and facilitates their detection, quality check and extraction.
Younesi et al. Journal of Biomedical Semantics 2014, 5:31 Page 7 of 11
http://www.jbiomedsem.com/content/5/1/31described in the application scenario. Finally, the ability to
use the CSEO in different systems may be facilitated
by the BFO upper-level ontology. Thus, various sub-
ontologies relevant to exposure can be integrated with
the ExO-CSEO structure under the BFO framework.
Similar to other ontologies, the CSEO suffers from the
sparse granularity and misclassification of concepts in
some parts of the ontology. Other shortcomings common
to all ontologies such as missing concepts, lack of standard
definitions, and incompleteness of synonym lists should be
addressed by engagement of the research community and
inclusion of their feedback in the process of ontology
enrichment. To facilitate the community contribution, a
website has been prepared with the aim of collecting users’
feedback and providing access to the latest version of the
ontology. With the public release of the ontology, it is
hoped to reach out to the broader community and collect
feedback and comments, which will be integrated in the
future versions of the CSEO and be used to improve the
ontology. With the version 1.0 of the CSEO, the ontology
is sufficiently established to be useful for the scientific
community. Furthermore, the project team will continue
to review articles, abstracts, and other resources relevant
for the domain and to extract novel terms and synonyms.
New releases of the CSEO will be announced and made
available through the NCBO’s bioportal.
Conclusions
With the creation of the CSEO including relevant terms
for describing exposure experiments, it can serve as a
powerful glossary for definition finding and relationship
visualization, facilitating the right use of terms. The
CSEO has the potential to grow in the future and be used
as a dictionary for various processes such as controllinginternal documents (e.g. Excel Workbooks) or efficient use
of Laboratory Information Management Systems (LIMS).
This functionality can be used for the identification of
relevant information (internally or publicly) or for the
extraction of relevant knowledge statements.
Methods
Defining scope of the CSEO
To define the scope, a qualitative survey was performed
involving various experts in the domain of environmental
exposure. Experts in toxicology, molecular biology, and
clinical pathology fields in PMI were consulted and asked
for their input on the concept classes that they deem
as necessary to describe the knowledge domain of
environmental exposure from their viewpoint. Based on
this input, boundaries of the knowledge domain to be pre-
sented by CSEO was determined as depicted in Figure 1.
Resources and tools
Different resources were used for construction of the
ontology (Additional file 4). General and common
concepts, for which an established ontological definition
exists, were captured. 44 publicly available ontologies
listed in Additional file 4 were re-used and the relevant
terms/classes/concepts were selectively integrated in the
CSEO along with their annotations. Specialized terms were
collected from various contributors mainly used for internal
process and workflow tracking in systems, such as Labora-
tory Information Management Systems (LIMS). Literature
sources either were searched by keywords (e.g. smoke, tox-
icity, cigarette, tobacco in PubMed) or were recommended
by experts (e.g. CORESTA publications or handbooks).
Additionally, relevant publicly available abstracts, a number
of relevant full-text articles, as well as “The Handbook of
Younesi et al. Journal of Biomedical Semantics 2014, 5:31 Page 8 of 11
http://www.jbiomedsem.com/content/5/1/31Cigarette Smoke Toxicity” by David Bernhard were
reviewed. Here, relevant text bodies were manually an-
notated, relevant terms were extracted and enriched
with synonyms and integrated into the ontology.
The Protégé 4.2 (Build 276) [57], developed and
maintained by The National Center for Biomedical
Ontology together with its inbuilt HermiT 1.3.3 reasoner
[58] were used to construct the ontology. The Knowtator
plugin [59] was used for manual annotation of abstracts
inside the Protégé environment. The text-mining tool
ProMiner [60] was utilized for named entity recognition
of ontology terms in PubMed abstracts and results
were integrated with SCAIView [61] for context-sensitive
visualization of query results.
Ontology development and evaluation process
During the process of ontology building, a hybrid ap-
proach combining both bottom-up and top-down
methods was adopted so that the ontology was popu-
lated at the level of superclasses and subclasses simul-
taneously. The development of the CSEO was
accomplished in four phases according to the common
life cycle of the ontology building [62].
Phase I: Knowledge acquisition and conceptualization
Concepts were extracted from previously identified
resources (see Additional file 4). Resources wereFigure 5 Mapping resources used for generating the ontology contenclassified into two groups based on their contents: struc-
tured content and unstructured content. Concepts from
structured contents such as tables, ontologies, and lists
were integrated automatically whereas concepts from
unstructured contents such as free text of publications
were manually inspected and extracted with the help of
annotation tools. Figure 5 describes the cardinal map-
ping of resources to the ontology contents. All concepts
in the ontology were annotated by additional informa-
tion including synonym(s), definition(s), and reference
(s). In the BFO version of the CSEO, relationships
among concepts were defined based on the standard re-
lation types in the Relation Ontology (RO) [63] and were
checked using the HermiT reasoner.
Phase II: Terminology analysis and concept enrichment
Transformation of the ontology OWL format into a
dictionary file was achieved using a Java script. The
script extracts concept names and the corresponding
synonyms from the ontology OWL structure and assigns
unique identifiers to each concept. This dictionary
was incorporated into ProMiner for named entity
recognition. In a subsequent step, the major super-
class concepts were used as keywords for queries in
PubMed. Five hundred relevant abstracts were chosen
from the result list of each concept search. After
compiling all abstracts, the corpus was randomlyts to their corresponding branches in the CSEO.
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(250 abstracts) using the randomization command in
Linux. To create the reference gold standard, suitable
annotation guidelines were developed so that annota-
tors are guided to keep the breadth and depth of the
ontology in mind. For enrichment purposes (here
optimizing both the ontology concepts and the corre-
sponding dictionary), the training set was analyzed for
false-negative entities, which — after individual expert
evaluation — was added to the ontology. Classes were an-
notated both manually and automatically by mapping them
to external ontologies. For this purpose, the National Cen-
ter for Biomedical Ontology (NCBO) was used [64]. CSEO
classes were manually annotated with equivalent external
ontology classes using an annotation property. These anno-
tations were then used to automatically retrieve synonym
information via the NCBO services. The evaluation process
required the performance comparison between automatic-
ally and manually annotated text from the same set.
Phase III: Evaluation
A metric-based approach evaluating the ontology was
used in three dimensions after the completion of the
ontology [65]. Structural evaluation was performed by
calculating features such as depth, breadth, and other
topological features. To evaluate the functional quality
of the ontology in terms of measuring the boundaries of
the knowledge domain it captures, precision, recall,
and F-score values were calculated. Precision is the
number of true positives (TP) divided by the sum of
TP and false positives (FP). Recall is the number of
TP divided by the number of results that should
have been returned (true positives (TP) + false nega-
tives (FN)). The F-score = 2 × (precision × recall)/
(precision + recall). These values were derived from
the longest string match found between automatically
annotated words using ProMiner and the human-curated
gold standard annotation for each abstract in the selected
corpus [66].
Phase IV: Visualization of concepts through the text
The ontology was integrated into the SCAIView literature
mining and visualization environment.
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